1.0
Jun 3, 2026
Former employee, more than 3 years
New Haven, CT
Recommend
CEO approval
Business Outlook
Pros
•it pays, but not a serious company. •no new data in 5-10 years, Viatris is a Pfizer pet project went wrong.
Cons
•New England respiratory was an unmitigated disaster. •Very little competent management , the company doesn’t seem interested in succeeding.